Imidex Hires Wes Bolsen As CEO To Commercialize FDA-Cleared Artificial Intelligence Device For Lung Nodule And Mass Detection, Indicative Of Potential Early-Stage Lung Cancer
(MENAFN - GlobeNewsWire - Nasdaq) Company is evaluating strategic partners and potential acquirers who could potentially treat 50% more lung nodule patients in the U.S. and save billions of dollars ...